E-cigarette, or Vaping, product use-Associated Lung Injury (EVALI): a diagnosis of exclusion
https://doi.org/10.18093/0869-0189-2024-4604
Abstract
EVALI (e-cigarette or vaping product use-associated lung injury) is a relatively new disease with complex differential diagnosis, as it mimics the clinical and pathological picture of various pulmonary diseases. The diversity of clinical manifestations of the disease described in the literature necessitates for treating EVALI as a diagnosis of exclusion and requires accumulation and understanding of the data to develop effective methods for diagnosis and patient management. The aim of the work was to present a clinical observation of vaping-associated lung injury (EVALI) in an adolescent as a diagnosis of exclusion. Conclusion. The presented clinical case demonstrates vaping-associated lung injury in a 15-year-old girl and the importance of high-quality collection of medical history for timely and correct diagnosis.
About the Authors
S. A. Tsarkova
Federal State Budget Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation; State Autonomous Healthcare Institution of the Sverdlovsk Region “Children’s City Clinical Hospital No.11, Ekaterinburg”
Russian Federation
Competing Interests:
Russian Federation
Sofya A. Tsarkova, Doctor of Medicine, Professor, Head of the Department of Outpatient Pediatrics; Deputy Chief Physician for Research
ul. Repina 3, Ekaterinburg, 620028;
ul. Nagornaya 48, Ekaterinburg, 620028;
tel.: (982) 600-41-10
Competing Interests:
The authors declare no conflict of interest.
I. V. Leshchenko
Federal State Budget Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation; Ural Federal Research Institute of Phthisiology and Pulmonology – a Branch of National Medical Research Center for Phthisiology, Pulmonology and Infectious Diseases, Healthcare Ministry of Russia; Limited Liability Company “Novaya bol’nitsa” Clinical Association
Russian Federation
Competing Interests:
Russian Federation
Igor V. Leshсhenko, Doctor of Medicine, Professor; Professor, Department of Infectious Diseases, Phthisiology and Pulmonology; Chief Researcher; Scientific Director; Honored Doctor of the Russian Federation
ul. Repina 3, Ekaterinburg, 620028;
ul. 22-go Parts’ezda 50, Ekaterinburg, 620039;
ul. Zavodskaya 29, Ekaterinburg, 620109;
tel.: (912) 288-28-23
Competing Interests:
The authors declare no conflict of interest.
A. I. Ivanova
State Autonomous Healthcare Institution of the Sverdlovsk Region “Children’s City Clinical Hospital No.11, Ekaterinburg”
Russian Federation
Competing Interests:
Russian Federation
Albina I. Ivanova, Head of the Senior Pediatric Department
ul. Nagornaya 48, Ekaterinburg, 620028;
tel.: (919) 370-16-78
Competing Interests:
The authors declare no conflict of interest.
V. R. Lipina
State Autonomous Healthcare Institution of the Sverdlovsk Region “Children’s City Clinical Hospital No.9, Ekaterinburg”
Russian Federation
Competing Interests:
Russian Federation
Valentina R. Lipina, Candidate of Medicine, Clinical Pharmacologist, Allergist-Immunologist, Pulmonologist, Pediatrician
ul. Reshetskaya 51, Ekaterinburg, 620134;
tel.: (912) 266-71-31
Competing Interests:
The authors declare no conflict of interest.
Z. A. Tsareva
State Autonomous Healthcare Institution of the Sverdlovsk Region “Children’s City Clinical Hospital No.9, Ekaterinburg”
Russian Federation
Competing Interests:
Russian Federation
Zhanna A. Tsareva, Allergist-Immunologist, Pulmonologist, Pediatrician
ul. Reshetskaya 51, Ekaterinburg, 620134;
tel. (912) 210-44-56
Competing Interests:
The authors declare no conflict of interest.
References
1. Vess K.B., Ivan N., Boscia J. E-cigarette-/vape-associated lung injury as a cause of interstitial lung disease. Cureus. 2024. 13; 16 (4): e58199. DOI: 10.7759/cureus.58199.
2. Cornelius M.E., Loretan C.G., Jamal A. еt al. Tobacco product use among adults. United States, 2021. MMWR Morb. Mortal. Wkly. Rep. 2023; 72 (18): 475–483. DOI: 10.15585/mmwr.mm7218a1.
3. Erhabor J., Boakye E., Obisesan O. еt al. E-cigarette use among US adults in the 2021 behavioral risk factor surveillance system survey. JAMA Netw Open. 2023; 6 (11): e2340859. DOI: 10.1001/jamanetworkopen.2023.40859.
4. Jonas A. Impact of vaping on respiratory health. BMJ. 2022; 18: 378: e065997. DOI: 10.1136/bmj-2021-065997.
5. Salagay O.O., Antonov N.S., Sakharova G.M. [Analysis of the structure and dynamics of consumption of tobacco and nicotine-containing products in the Russian Federation in 2019–2022]. Profilakticheskaya medicina. 2022; 25 (9): 15–23. DOI: 10.17116/profmed20222509115 (in Russian).
6. Jackler R.K., Chau C., Getachew B.D. et al. JUUL advertising over its first three years on the market. Welch Road: Stanford Publishing; 2019. Available at: https://tobacco-img.stanford.edu/wp-content/uploads/2021/07/21231836/JUUL_Marketing_Stanford.pdf
7. Dutra L.M., Glantz S.A. High international electronic cigarette use among never smoker adolescents. J. Adolesc. Health. 2014; 55 (5): 595–597. DOI: 10.1016/j.jadohealth.2014.08.010.
8. Wang T.W., Neff L.J., Park-Lee E. et al. E-cigarette use among middle and high school students – United States, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020; 69 (37): 1310–1312. DOI: 10.15585/mmwr.mm6937e1.
9. Lim C.C.W., Sun T., Leung J. et al. Prevalence of adolescent cannabis vaping: a systematic review and meta-analysis of US and Canadian studies. JAMA Pediatr. 2022; 176 (1): 42–51. DOI: 10.1001/jamapediatrics.2021.4102.
10. Zulfiqar H., Sankari A., Rahman O. Vaping-associated pulmonary injury. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK560656/
11. Ozerskaya I.V., Malakhov A.B., Sedova A.Yu. et al. [Vaping-associated lung damage in a teenager]. Terapevticheskiy arkhiv. 2024; 96 (1): 53–57. DOI: 10.26442/00403660.2024.01.202561 (in Russian).
12. Krishnasamy V.P., Hallowell B.D., Ko J.Y. et al. Update: characteristics of a nationwide outbreak of e-cigarette, or vaping, product ase-associated lung injury – United States, August 2019 – January 2020. MMWR Morb. Mortal. Wkly. Rep. 2020; 69 (3): 90–94. DOI: 10.15585/mmwr.mm6903e2.
13. Lilly C.M., Khan S., Waksmundzki-Silva K., Irwin R.S. Vaping-associated respiratory distress syndrome: case classification and clinical guidance. Crit .Care Explor. 2020; 2 (2): e0081. DOI: 10.1097/CCE.0000000000000081.
14. Podzolkov V.I., Vetluzhskaya M.V., Abramova A.A. et al. [Vaping and vaping-associated lung injury]. Terapevticheskiy arkhiv. 2023; 95 (7): 591–596. DOI: 10.26442/00403660.2023.07.202293 (in Russian).
Supplementary files
Review
For citations:
Tsarkova S.A., Leshchenko I.V., Ivanova A.I., Lipina V.R., Tsareva Z.A. E-cigarette, or Vaping, product use-Associated Lung Injury (EVALI): a diagnosis of exclusion. PULMONOLOGIYA. 2025;35(1):110-117. (In Russ.) https://doi.org/10.18093/0869-0189-2024-4604
Views:
706
Email this article 